Claims by China-based stem cell broker misleading

In a pair of reports, Milwaukee Journal Sentinel reporters Mark Johnson and Meg Kissinger examined the overblown medical claims and misleading marketing strategies of China-based Beike Biotechnology, one of many overseas operations marketing experimental stem cell treatments to desperate American families. The two interviewed dozens of the top doctors and scientists in their respective fields and found that the company relies on faulty science and flawed theories, has misled patients about success rates and exaggerated its own medical credentials. On the marketing side, after interviews with the families of dozens of those who received treatments, the two found the company trolls for patients on the Internet and relies on a commission-based system for marketing agents who the company admits it has little control over.